Literature DB >> 20577906

Isolated sleep paralysis linked to impaired nocturnal sleep quality and health-related quality of life in Chinese-Taiwanese patients with obstructive sleep apnea.

Sun-Wung Hsieh1, Chiou-Lian Lai, Ching-Kuan Liu, Sheng-Hsing Lan, Chung-Yao Hsu.   

Abstract

PURPOSE: Isolated sleep paralysis (ISP) is a rapid eye movement (REM) sleep parasomnia and has a special meaning in Chinese population. Worsening of obstructive sleep apnea (OSA) occurs especially during REM sleep. The relationship between ISP and OSA is unclear. The aim of this study was to investigate the impact of ISP on sleep and life quality in Chinese-Taiwanese OSA patients.
METHODS: We recruited 107 OSA patients diagnosed by polysomnography (PSG) in Southern Taiwan. ISP was evaluated by self-reported sleep questionnaire. We used Chinese version of Epworth Sleepiness Scale (ESS), Pittsburgh Sleep Quality Index (PSQI), and Short-Form 36 (SF36) to evaluate daytime sleepiness, nocturnal sleep quality, and health-related quality of life, respectively for OSA patients. Student's t-test was used to compare PSG parameters, ESS, PSQI, physical and mental component of SF-36 (P-SF36 and M-SF36) between OSA patients with and without ISP. Stepwise multiple regression was used to find out the factors independently associated with ESS, PSQI, P-SF36, and M-SF36.
RESULTS: Forty-one of 107 patients (38.3%) had ISP. It showed no significant difference in PSG parameters between OSA patients with and without ISP. OSA patients with ISP had significantly higher ESS (P = 0.010), higher PSQI (P = 0.007), lower P-SF36 (P = 0.020), and lower M-SF36 (P = 0.001) than those without ISP. ISP was an independent factor associated with ESS (P = 0.017), PSQI (P = 0.001), and M-SF36 (P = 0.030) after adjusting for other confounding variables.
CONCLUSIONS: ISP was independently associated with excessive daytime sleepiness, worse sleep quality, and impaired mental health-related quality of life in Chinese-Taiwanese OSA patients.

Entities:  

Mesh:

Year:  2010        PMID: 20577906     DOI: 10.1007/s11136-010-9695-4

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  37 in total

Review 1.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.

Authors: 
Journal:  Sleep       Date:  1999-08-01       Impact factor: 5.849

2.  Validation of a Chinese version of the Epworth sleepiness scale.

Authors:  Ning-Hung Chen; Murray W Johns; Hseuh-Yu Li; Chia-Chen Chu; Shu-Cheng Liang; Yu-Hsiang Shu; Ming-Lung Chuang; Pa-Chun Wang
Journal:  Qual Life Res       Date:  2002-12       Impact factor: 4.147

3.  Psychometric evaluation of the Chinese version of the Pittsburgh Sleep Quality Index (CPSQI) in primary insomnia and control subjects.

Authors:  Pei-Shan Tsai; Shu-Yi Wang; Mei-Yeh Wang; Chein-Tien Su; Tsung-Tsair Yang; Chun-Jen Huang; Su-Chen Fang
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

4.  Risk factors for isolated sleep paralysis in an African American sample: a preliminary study.

Authors:  Holly J Ramsawh; Susan D Raffa; Kamila S White; David H Barlow
Journal:  Behav Ther       Date:  2008-06-06

5.  Clinical manifestations and consequences of obstructive sleep apnea.

Authors:  Joshua B Wenner; Rupi Cheema; Najib T Ayas
Journal:  J Cardiopulm Rehabil Prev       Date:  2009 Mar-Apr       Impact factor: 2.081

6.  Apnea duration and hypoxemia during REM sleep in patients with obstructive sleep apnea.

Authors:  L J Findley; S C Wilhoit; P M Suratt
Journal:  Chest       Date:  1985-04       Impact factor: 9.410

7.  'The devil lay upon her and held her down'. Hypnagogic hallucinations and sleep paralysis described by the Dutch physician Isbrand van Diemerbroeck (1609-1674) in 1664.

Authors:  E J O Kompanje
Journal:  J Sleep Res       Date:  2008-08-05       Impact factor: 3.981

8.  The occurrence of sleep-disordered breathing among middle-aged adults.

Authors:  T Young; M Palta; J Dempsey; J Skatrud; S Weber; S Badr
Journal:  N Engl J Med       Date:  1993-04-29       Impact factor: 91.245

Review 9.  Epidemiology, risk factors, and consequences of obstructive sleep apnea and short sleep duration.

Authors:  Nabil M Al Lawati; Sanjay R Patel; Najib T Ayas
Journal:  Prog Cardiovasc Dis       Date:  2009 Jan-Feb       Impact factor: 8.194

10.  Sympathetic neural mechanisms in obstructive sleep apnea.

Authors:  V K Somers; M E Dyken; M P Clary; F M Abboud
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

View more
  6 in total

1.  Unique sleep disorders profile of a population-based sample of 747 Hmong immigrants in Wisconsin.

Authors:  Eric Young; Se Xiong; Laurel Finn; Terry Young
Journal:  Soc Sci Med       Date:  2012-07-02       Impact factor: 4.634

2.  Risk factors of sleep paralysis in a population of Polish students.

Authors:  Paulina Wróbel-Knybel; Michał Flis; Joanna Rog; Baland Jalal; Hanna Karakuła-Juchnowicz
Journal:  BMC Psychiatry       Date:  2022-06-07       Impact factor: 4.144

Review 3.  A clinician's guide to recurrent isolated sleep paralysis.

Authors:  Brian A Sharpless
Journal:  Neuropsychiatr Dis Treat       Date:  2016-07-19       Impact factor: 2.570

Review 4.  Relationships between sleep paralysis and sleep quality: current insights.

Authors:  Dan Denis
Journal:  Nat Sci Sleep       Date:  2018-11-02

5.  Sleep Paralysis, a Medical Condition with a Diverse Cultural Interpretation.

Authors:  Esther Olunu; Ruth Kimo; Esther Olufunmbi Onigbinde; Mary-Amadeus Uduak Akpanobong; Inyene Ezekiel Enang; Mariam Osanakpo; Ifure Tom Monday; David Adeiza Otohinoyi; Adegbenro Omotuyi John Fakoya
Journal:  Int J Appl Basic Med Res       Date:  2018 Jul-Sep

6.  Prevalence and Clinical Picture of Sleep Paralysis in a Polish Student Sample.

Authors:  Paulina Wróbel-Knybel; Hanna Karakuła-Juchnowicz; Michał Flis; Joanna Rog; Devon E Hinton; Piotr Boguta; Baland Jalal
Journal:  Int J Environ Res Public Health       Date:  2020-05-18       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.